Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWater Intel. Regulatory News (WATR)

Share Price Information for Water Intel. (WATR)

Share Price is delayed by 15 minutes
Get Live Data
247.50    -4.00 (-1.64%)
Bid:
240.00
Ask:
255.00
Spread: 15.00 (6.25%)
Market Cap: £40.41m
WATR Live PriceLast checked at - London Stock Exchange

Intraday Water Intel. Share Chart

Management Changes

8 Oct 2008 07:00

RNS Number : 3184F
Qonnectis plc
08 October 2008
 

Qonnectis plc ("Qonnectis" or the "Company")

Management Changes

Due to the current ill health of Chief Executive Michael Tapia the Board announces that Guy Chant, currently a Non Executive Director of the Company will act as interim Chief Executive with immediate effect during this period.

Guy has had extensive experience within the European utilities industry, at both senior management and Board levels. Between 1994 and 1999 he was Managing Director of Thames Municipal Products Ltd ("TMP"). Between 2000 and 2004 he was Commercial Director of Thames Water Utilities Ltd and External Affairs Director of Thames Water plc. More recently, Guy was Executive Director at Berlinwasser Holding AG (a joint venture between Land Berlin, RWE/Thames Water ("RWE") and Veolia Environnement S.A.), the main water utility serving the city of Berlin.

The Board is pleased to announce that Barbara Spurrier has been appointed finance director with immediate effect.

Barbara is a qualified certified accountant with over 25 years experience in financial and accountancy roles. She is a founder and Director of Cambridge Equity Partners Ltd., a consultancy business focussing on corporate finance projects, where she has worked with numerous companies to develop strategic business plans and objectives. Barbara has experience in assisting companies to secure capital from institutions and private investors in order to facilitate expansion and development, and has undertaken full business reviews to identify and provide action on key issues.

As previously announced the Company expects to release its preliminary announcement of the results for the year ended 30 June 2008, in November 2008.

Enquiries:

Qonnectis plc 01932 788299 

Guy Chant

Barbara Spurrier

Finncap 0207 600 1658

Clive Carver

Appendix

In accordance with Schedule Two, paragraph (g) of the AIM Rules for Companies, the following information in relation to the appointment of Barbara Spurrier to the Board is disclosed:

Full name: Barbara Joyce Spurrier

Previous names: Barbara Joyce Huxley-Parlour

Barbara Joyce Gagg

Age: 52

Barbara Spurrier currently holds or has held the following directorships and partnerships in the last five years.

Current Directorships and Partnerships

Directorships held in the last five years

Cambridge Equity Partners Ltd.

CBIOS Ltd.

Cambridge Financial Partners LLP

Cellexus Biosystems Inc. 

Cellexus Biosystems Plc.

DCM Incontrol Ltd.

Fair 2 U Ltd.

Freshbourne Ltd 

OxLoc Ltd.

Renewable Energy fuels Worldwide Ltd.

Rototek Ltd

SG32 Ltd

Stribbons Ltd.

TDLP Associates Ltd.

Barbara Spurrier has been a director of the following:

Cellexus Biosystems Plc which was put into administrative receivership on 3 March 2008.

Strathcarron Sports Cars plc which was put into voluntary creditors liquidation on 21 November 2001 with an estimated deficiency as regards creditors of £2,633,000.

J. A. Gagg & Sons Limited which became insolvent under receivership rule 3.32 and was dissolved on 18 November 1997.

There are no further disclosures to be made in relation to Barbara Spurrier pursuant to Schedule Two, paragraph (g) of the AIM Rules for Companies.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRUBUNRWRRRRAA
Date   Source Headline
25th Apr 20197:00 amRNSWater Intelligence International Wins
4th Apr 20197:00 amRNSSale of New Franchise in Georgia
28th Mar 20197:00 amRNSReacquisition of Orlando, Florida Franchise
12th Mar 20197:00 amRNS2018 Full Year Trading Results
7th Mar 20197:00 amRNSReacquisition of South Atlanta Franchise
5th Feb 20197:00 amRNSCorporate Transactions and Technology Update
17th Jan 20197:01 amRNSDirectorate Change
17th Jan 20197:00 amRNSAppointment of NOMAD & Broker
8th Jan 20194:40 pmRNSSecond Price Monitoring Extn
8th Jan 20194:35 pmRNSPrice Monitoring Extension
21st Dec 20187:00 amRNSContract Win
4th Dec 20187:00 amRNSTrading Statement
11th Oct 20182:00 pmRNSPrice Monitoring Extension
9th Oct 20187:00 amRNSReacquisition of Portland
12th Sep 20187:00 amRNSInterim Results
31st Jul 20187:00 amRNSFirst Half Trading Update
26th Jun 20187:00 amRNSJoint Technology Development Agreement
19th Jun 20184:20 pmRNSResult of AGM
29th May 20187:00 amRNSPosting of Annual Report and Notice of AGM
17th May 20187:07 amRNSResults for the year ended 31 December 2017
15th May 20187:00 amRNSAcquisition of South Florida Franchise
10th May 20188:24 amRNSHolding(s) in Company
25th Apr 20187:00 amRNSQ1 Trading Update
13th Apr 20183:52 pmRNSHolding(s) in Company
19th Mar 20181:36 pmRNSHolding(s) in Company
19th Mar 20181:31 pmRNSHolding(s) in Company
16th Mar 20184:53 pmRNSHolding(s) in Company
15th Mar 20187:00 amRNSAcquisition
7th Mar 20189:00 amRNSCompletion of Fundraise
7th Mar 20187:00 amRNSProposed Fundraising and Acquisition
26th Feb 20187:00 amRNSNew Contract for Sydney Corporate Store
14th Feb 20187:00 amRNSQ4 Trading Update and Corporate Development
11th Jan 20188:26 amRNSExercise of Options and PDMR Dealing
10th Jan 20187:00 amRNSALD and Flo Technologies Partnership
4th Jan 20187:00 amRNSSecond National Insurance Agreement Signed
21st Dec 20177:00 amRNSNew Strategic Relationships
2nd Nov 20177:00 amRNSQ3 Trading Update
21st Sep 20172:58 pmRNSHolding(s) in Company
7th Sep 20173:21 pmRNSExercise of Options and PDMR Dealing
7th Sep 20177:00 amRNSInterim Results
9th Aug 20177:00 amRNSTrading Update and Acquisition
20th Jun 201711:55 amRNSResult of AGM
13th Jun 20177:00 amRNSJanuary to April Trading Update
8th Jun 20178:24 amRNSPosting of Annual Report and Notice of AGM
7th Jun 20177:00 amRNSAcquisition of Indianapolis Franchise
22nd May 20177:00 amRNSAmerican Pool Enterprises Agreement
16th May 20177:00 amRNSFinal Results
8th May 20177:00 amRNSOpening of Washington DC Corporate Operations
9th Feb 20177:00 amRNSQ4 Trading Update and Year-End Corporate Items
6th Feb 20177:00 amRNSNational Insurance Agreement Signed

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.